Telemedicine in Asthma Management:
What Clinicians Need to Know

Released On
January 26, 2021

Expires On
January 26, 2022

Media Type
Internet

Completion Time
60 minutes

Specialty
Allergy & Immunology, Pharmacy, Primary Care

Topic(s)
Asthma

Scroll to the Bottom of this Information to Begin this Course

Jointly provided by The Potomac Center for Medical Education and Rockpointe.

 

In collaboration with the American Lung Association.

This program is supported by unrestricted educational grants from AstraZeneca, Sanofi Genzyme and Regeneron Pharmaceuticals.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit
  • Physicians — maximum of 1.0 ABIM MOC points
  • Pharmacists — maximum of 1.0 hour (0.10 CEUs) of continuing education credit (UAN number 0418-9999-21-001-H01-P)
  • Nurses — 1.0 Contact Hour

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

The intended audience for this educational initiative is primary care clinicians, allergists, immunologists, pharmacists, nurses, and other healthcare providers involved in the care of patients with asthma.

Program Overview

Telemedicine is becoming an increasingly common component of healthcare, driven by patient demand and vast improvements in technology. While the integration of telemedicine into daily practice in asthma management has been studied and implemented to a limited extent in over the last decade, many allergist and immunologists have had the need for telemedicine thrust upon them very suddenly. Thus, they lack familiarity with the benefits of telemedicine and are likely uncertain on how best to manage patient care in this virtual setting. Hence, these clinicians will require education on best practices for incorporating telemedicine in the asthma and allergist clinic, including different strategies for virtual healthcare visits and remote patient monitoring, how to manage treatment in the telemedicine setting, and how to navigate the complex and continuously evolving legal and regulatory landscape pertaining to telehealthcare. This program will provide clinicians with the most up-to-date information on telemedicine in asthma care to promote easier transitions to this new and necessary form of care for their patients.

Agenda

Welcome and Introduction
Telemedicine in the Allergy/Immunology Practice
Guidance for Implementing Telemedicine for Patients with Asthma
Asthma Telemedicine: Navigating the Legal and Regulatory Issues
Q&A Session

Learning Objectives

The proposed initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine. At the conclusion of this education, participants should be able to:

This program is designed to address ACPE competencies, including foundational knowledge, and approach to practice and care.

  • Describe the benefits and challenges of telemedicine in the asthma/allergy clinic
  • Adopt recommended practices for appropriate integration of telemedicine into asthma patient care
  • Assess the legal and regulatory guidelines and requirements for asthma care via telemedicine

Faculty

Wanda Phipatanakul, MD, MS

Professor of Pediatrics
Harvard Medical School
Director, Asthma Clinical Research Center
Boston Children's Hospital
Boston, MA

Jay M. Portnoy, MD

Professor of Pediatrics
University of Missouri-Kansas City School of Medicine
Staff Allergist and Medical Director of Telemedicine
Children’s Mercy Hospital
Kansas City, MO

Jodi Shroba, MSN, APRN, CPNP

Certified Pediatric Nurse Practitioner
Food Allergy Program Coordinator, Allergy Division
Children’s Mercy Hospital
Kansas City, MO

Ashley M. Thomas, PharmD, BCPS, BCACP, CACP

Clinical Pharmacy Specialist, Primary Care
Nashville, TN

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation Statement

The Potomac Center for Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program, please email: contact@potomacme.org.

ABIM MOC Designation Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

Pharmacist Accreditation Statement

The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Pharmacist Credit Designation Statement

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 contact hour (0.10 CEUs) of continuing education credit (UAN number 0418-9999-21-001-H01-P).

This is an application-based activity.

For information about this continuing pharmacy education (CPE) activity, please email: contact@potomacme.org.

Nursing Credit Statement

This nursing continuing professional development activity was approved by the Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosures of Conflicts of Interest

The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

Program Faculty

The faculty, authors and content developers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Wanda Phipatanakul, MD, MS: Consultant/Independent Contractor: Genentech/Novartis, GlaxoSmithKline, Regeneron/Sanofi; Grant/Research Support: Alk Abello, Circassia, Genentech/Novartis, Kaleo, Regeneron/Sanofi

Jay M. Portnoy, MD: Nothing to disclose

Jodi Shroba, MSN, APRN, CPNP Honoraria: Aimmune; Speaker's Bureau: Aimmune

Ashley M. Thomas, PharmD, BCPS, BCACP, CACP: Nothing to disclose

Planners and Managers

The planners and mangers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Chad Williamson, MS, MBA, CMPP: Nothing to disclose

Content Reviewers

The content reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Katie Propst, PhD: Nothing to disclose

Lindsay Scott, PT, DPT, ATC: Nothing to disclose

Instructions for Participation and Credit

There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive credit for participation, participants must complete the post-test (achieving a passing grade of 66%) and program evaluation. Certificates can be printed immediately.

Instructions for Participants and Obtaining CME/CPE/MOC Credit

There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME/CNE/CPE/MOC activity in its entirety, and then complete the post-test, with a score of 66% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.

Hardware and Software Requirements

Please ensure the computer system you plan to use meets the following minimum requirements:

  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac & Windows): Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML

FDA Disclosure

The contents of some CME/CNE/CPE/MOC activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Click here for the PCME Privacy Policy